Top compounds associated with response to LSMEM2


Feature Type Standardized
Nominal ANOVA
mRNA SL 0101-1 GDSC1000 pan-cancer AAC -0.07 0.06
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.066 0.06
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.068 0.06
mRNA paclitaxel gCSI pan-cancer AAC 0.099 0.06
mRNA BRD-K66453893 CTRPv2 pan-cancer AAC 0.057 0.06
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC 0.096 0.07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.07
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.07
mRNA Topotecan CCLE pan-cancer AAC -0.076 0.07
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC 0.13 0.07
Download CSV